Bayesian Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bayesian Capital Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,611	Closed	-$249K	–	1170
2024 Q1	$249K	Buy	+13,611	New	+$216K	0.02%	607
2023 Q1	–	Sell	-9,226	Closed	-$488K	–	1155
2022 Q4	$488K	Buy	+9,226	New	+$449K	0.07%	363
2021 Q2	–	Sell	-6,800	Closed	-$344K	–	694
2021 Q1	$344K	Buy	+6,800	New	+$378K	0.08%	325

Other funds holding SILK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bayesian Capital Management's SILK Position: Q2 2024 in Review

Bayesian Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 13,611 shares — an estimated $249K sold.

Bayesian Capital Management first reported a position in SILK in Q1 2021 and held it in 3 quarters. The position peaked at $488K in Q4 2022. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

Bayesian Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bayesian Capital Management sold 13,611 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $249K.
Bayesian Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Bayesian Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $488K in Q4 2022.
172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.